MTAP and glioblastoma: On the other hand, only 7.4% of the G-CIMP glioblastomas showed loss of MTAP, which is associated with secondary glioblastoma, tumor-harboring mutation of the IDH1 gene, and lesions that progressed from LGG [16,57,58].